|
|||||
|
|
Carcinoma of Unknown Primary with EML4-ALK Fusion Response to ALK Inhibitors |
|
| Authors: | Peng Zhao Ling Peng Wei Wu Yi Zheng Weiqin Jiang Hangyu Zhang Zhou Tong Lulu Liu Ruobing Ma Liping Wang Ming Yao Kai Wang Weijia Fang Liming Wu |
| Affiliation: | 1. Cancer Biotherapy Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China Contributed equally;2. Department of Radiotherapy, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China Contributed equally;3. Cancer Biotherapy Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;4. OrigiMed, Shanghai, China;5. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China |
| Abstract: | |
| Keywords: | Carcinoma of unknown primary EML4-ALK fusion Next-generation sequencing ALK inhibitor |